About Quantapore
Quantapore is a company based in San Francisco (United States) founded in 2009. Quantapore has raised $50.55 million across 3 funding rounds from investors including Sangel Capital, Baidu Ventures and Cloudstone Capital. The company has 17 employees. Quantapore offers products and services including Nanopore Analytical Platforms. Quantapore operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and GenapSys, among others.
- Headquarter San Francisco, United States
- Employees 17
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website quantapore.com
- Social LinkedIn
- Legal Name Quantapore Inc
- Total Equity Funding$50.55M (USD)
in 3 rounds
- Latest Funding Round$15.55M (USD), Series C
Jul 2018
- InvestorsSangel Capital
& 4 more
- Employee Count17
Products & Services of Quantapore
Quantapore offers a comprehensive portfolio of products and services, including Nanopore Analytical Platforms.
Tools for single-molecule analysis in proteomics and genomics research
Funding Insights of Quantapore
Quantapore has successfully raised a total of $50.55M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $15.55 million completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $50.55M
- Total Rounds 3
- Last Round Series C — $15.55M
- First Round $35M
(May 2014)
- Investors Count 5
All 3 funding rounds of Quantapore with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2018 | $15.55M | Series C | – | Northern Light Venture Capital | |
| Sep 2016 | – | Series C | – | – | – |
| May 2014 | $35M | Series B | – | – | – |
5 investors in total: 5 institutional.
Investors in Quantapore
Quantapore has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Sangel Capital, Baidu Ventures and Cloudstone Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A venture capital firm focused on life sciences investments. | – | sangelvc.com | Shenzhen, China | |
Cloudstone Capital is engaged in venture capital investments focusing on healthtech. | 2016 | cloudstonevc.com | Redwood City, United States | |
Provider of early stage venture capital focused on technology companies | – | nlvc.com | Menlo Park, United States | |
Venture capital fund focused on pre-seed tech startups | – | foothill.ventures | Los Altos, United States | |
- | – | bv.ai | - |
Investor details for Quantapore
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Quantapore
21 people are tracked at Quantapore (5 in leadership, 9 in board & advisors, 7 in team); the tracked headcount is 17.
| Name | Role | Group |
|---|---|---|
Joshua Stahl | CEO | Leadership |
Martin Huber | CTO | Leadership |
Ossama Assad | Director of Sequencing and Nanofab | Leadership |
Stuart Davidson | VP of Software at Quantapore Inc. | Leadership |
Milya Davlieva | Vice President of Research and Development | Leadership |
Adam R. Hall | Scientific Advisory Board Member | Board & advisors |
Steven Boxer | Scientific Advisory Board Member | Board & advisors |
Alex Dickinson | Director | Board & advisors |
Sascha C. Dennstedt | Co-founder & Director | Board & advisors |
William Greenleaf | Scientific Advisor | Board & advisors |
Michael Snyder | Scientific Advisor | Board & advisors |
Sean Stalfort | Director | Board & advisors |
Feng Deng | Board Member | Board & advisors |
Jason Myers | Scientific Advisory Board Member | Board & advisors |
Andrew Kotila | Process Development Engineer | Team |
Licen Xu | Product Expert | Team |
Jaycee Pang | Associate Researcher | Team |
MINH TON | Scientist, Molecular Biology | Team |
Cecilia (Hanxu) Zhang | Research associate | Team |
RUOYING LU | Senior Scientist | Team |
1 more people are available in the full profile.
Complete people profiles for Quantapore
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Quantapore
3 dated milestones of Quantapore across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Quantapore is founded.
- Funding First funding round of $35.0M.
- Funding Latest funding round, Series C, of $15.6M.
Competitors of Quantapore
Quantapore operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and GenapSys, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nanoporetech.com | 2005 | Oxford, United Kingdom | $1.26B | 705 | Nanopore-based electronic systems for single-molecule analysis are developed. | |
| pacb.com | 2004 | Menlo Park, United States | $395M | 649 | Instrument systems and software for single-molecule real-time sequencing are developed. | |
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| completegenomics.com | 2006 | San Jose, United States | $124.99M | 70 | DNA sequencing platform for human genome analysis is developed. | |
| genapsys.com | 2010 | Redwood, United States | $313.03M | 60 | Provider of DNA sequencing technologies for applied genomic testing and medical sequencing | |
| raindancetech.com | 2004 | Billerica, United States | $111.66M | 105 | Developer of nucleic acid detection and quantification systems | |
| quantumdx.com | 2008 | Newcastle Upon Tyne, United Kingdom | $57.26M | 98 | Handheld diagnostic and sequencing devices are developed for personalized healthcare. | |
| tierrabiosciences.com | 2015 | Berkeley, United States | $31.56M | 11 | AI-based tools for protein development and custom synthesis are offered. | |
| purigenbio.com | 2012 | Pleasanton, United States | $88.32M | 24 | Isotachophoresis technology is provided for nucleic acid sample preparation. |
Detailed competitors of Quantapore
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quantapore
Complete news archive for Quantapore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Quantapore
10 companies that operate in the same segment as Quantapore (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Quantapore
Quantapore was founded in 2009 and raised its 1st funding round 5 years after it was founded.
Quantapore is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Quantapore is a funded company, having raised a total of $50.55M across 3 funding rounds to date. The company's 1st funding round was a Series B of $35M, raised on May 2014.
Quantapore has 17 employees.
Quantapore was founded in 2009 in San Francisco, United States, within the biotechnology sector. Proprietary DNA sequencing technology is developed, relying on optically labeled nanopores for energy transfer interactions with labeled nucleic acid samples. Quantum-optic interactions between nanopores and DNA are employed to support single-molecule sequencing processes. Operations focus on advancing nucleic acid analysis methods for improved efficiency in speed and cost.
Quantapore offers Nanopore Analytical Platforms.
Quantapore has 5 investors. Key investors include Sangel Capital, Baidu Ventures, Cloudstone Capital, NLVC, and Foothill Ventures.
Quantapore operates through Quantapore Inc.